AGENT, an AI-driven framework integrating high-throughput experimentation with Bayesian optimization, enables the rapid engineering of thermostable, solid-state mRNA vaccines. These formulations retained full bioactivity after storage at 37 °C for 2 months, elicited immune responses non-inferior to fresh vaccines, and enabled cold-chain-free delivery via microneedle patches in rodents and nonhuman primates.